- Recalls of the Week
- Wall Street Journal Reports FDA Issues Warning that Prilosec and Nexium Can Interfere with Plavix
- Recalls of the Week
- American Bar Association's Magazine Runs Article Addressing Running a Solo Practice Featuing Yours Truly
- Recalls of the Week
- Recalls of the Week
- FDA Probes Orlistat (Alli and Xenical) For Link To Liver Damage
- Recalls of the Week
- New FDA Study Confirms Antidepressants (SSRIs) Increase Suicide Risks in Children & Young Adults
- Recalls of the Week
- Recalls of the Week ---Finally
- Chrysler/Fiat Get Off Scott Free From Existing and Future Products Liability Claims
- NY Times Reports: Synthetic Turf Fields Raise Safety Concerns for Children
- Recalls of the Week
- Recalls of the Week
- FDA Warns Hydroxycut Associated with Liver Injury; Manufacturer Recalls Hydroxycut Products from the Market
- Recalls of the Week
- The Toxic Chinese Drywall Drama Continues to Expand
- Recalls of the Week
- Drywall Manufactured in China Maybe Toxic
- Recalls of the Week
- AstraZeneca Hid Bad Studies on Seroquel; Agrees to Increase Warnings
- Raptiva, Drug to treat Psoriasis, Linked to Rare Brain Infection
- Recalls of the Week
- Recalls of the Week
- Lawyers USA Touts Solo Practice University and What it Can Offer the Solo Attorney
- Peanut Butter Recall: What's it all about???
- Zyprexa, Seroquel and Risperdal Increase Risk of Heart Failure
- Recalls of the Week
- FDA Updates Information Regarding Singulair and its Relation to Suicide
- Recalls of the Week
- Great Start to the New Year: Selected as Faculty Member of Solo Practice University
- Supreme Court Rules No Preemption in Cigarette Case
- Recalls of the Week (or Two)
- New York Times Reports on NPR Radio Host's Ties to Big Pharma: Did This Effect His Views on Anti-Depressants and Suicide
- Recalls of the Week
- Recalls of the Week
- FDA Issues Recall of Syringes Used by Diabetics
- Recalls of the Week
- FDA Issues Public Health Notification of Serious Problems With Surgical Mesh Used to Treat Pelvic Organ Prolapse and Urinary Incontinence in Women
- Recalls of the Week
- Genentech and FDA Announce New Black Box Warning for Raptiva
- Preemption - Wall Street Jounal Reports How Bush Trying to Take Away Right to Sue for Unsafe Products in His Final Days
- Recalls of the Week
- Recalls of the Week
- New York Times Reports on Study Indicating Older Antipsychotics Better for Children
- Recalls of the Week
- Recalls of the Week
- FDA Issues Further Warning on Diabetes Drug Byetta
- Wall Street Journal Reports New England Journal of Medicine Sides with Plaintiffs on Preemption
- Preemption: Taking Away Your Day in Court at Top of Supreme Court's List
- Recalls of the Week
- RECALLS OF THE WEEK------RETURNS (and so do I)
- Paxil: The Truth Revealed by Alison Bass
- Recalls of the Week
- Recalls of the Week
- Going Solo - I'm Defying Gravity
- Recalls of the Week (maybe two weeks)..
- The New York Observer Finds My Son - The Whirlwind Continues
- New York Times Publishes Son's Letter
- Birmingham News Reports Two People Injured in SUV Rollover on I-59
- Recalls of the Week
- Bayer Pulls Trasylol (Aprotinin) Completely From The Market
- Digitek Recall Still A Mystery
- Recalls of the Week
- Drug and Device Law - A Must for ALL Drug Lawyers
- Baxter Says Its Taken No Legal Hit from Heparin
- Recalls of the Week
- FDA Thinks FDA Contamination May Have Been Deliberate
- Recalls of the Week
- New York Times Addresses Concerns Raised About "Ghostwriting" of Drug Studies
- Ford Settles Class Action Regarding Ford Explorers and Rollovers
- Hillbilly Redneck Teeth Recalled
- AP Reports: Another Secret of the Pharmaceutical World to be Revealed: The Drs. Who Take Money and Trips from Big Pharma
- New York Times and Reader's Digest Address Problem of Preemption in Drug Cases, Part III
- Vytorin--Merck, Why Did You Wait So Long!?!
- New York Times and Reader's Digest Address Problem of Preemption in Drug Cases, Part II
- New York Times and Reader's Digest Address Problem of Preemption in Drug Cases, Part I
- Study Indicates Clinical Trials for Drugs Don't Include the Right People
- Crestor Study Ended Due to Good Results
- Business Week Magazine Addresses Federal Preemption Concern
- New York Times Addresses Preemption Concerns Led to Alaska Settlement of Zyprexa Claim
- Preemption and the Supreme Court: Our Rights Are Being Taken Away And Nobody Knows
- FDA Reviewing Potential Cancer Risk from Regranx, an Ulcer Drug
- FDA Warns About Suicidality with use of Singulair
- General Motors Settles Class Action regarding Dex-Cool Coolant
- FDA Still Sitting on the Trasylol Issue
- Products Liability Lawyer Begins His Push Into The Blogging World